United States

Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

21 Jul 2017
Change (% chg)

$-0.03 (-1.99%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

James Young

64 2011 Independent Chairman of the Board

Stanley Erck

68 2011 President, Chief Executive Officer, Director

Barclay Phillips

54 2013 Chief Financial Officer, Senior Vice President, Treasurer

Gregory Glenn

63 2016 President, Research and Development

John Herrmann

52 2014 Senior Vice President, General Counsel, Corporate Secretary